-
-
-
-
-
-
-
Nektar Therapeutics (NKTR) PT Raised to $178 at BTIG
-
-
-
-
-
-
-
Oppenheimer on Nektar Therapeutics (NKTR): 'meaningful opportunities for biologics in AA'
-
-
-
-
-
-
-
William Blair Upgrades Nektar Therapeutics (NKTR) to Outperform
-
-
-
-
-
-
-
Nektar Therapeutics (NKTR) Halted, News Pending
-
-
-
-
-
-
-
Nektar Therapeutics (NKTR) Strength Attributed to Rumor
-
-
-
-
-
-
-
Nektar Therapeutics (NKTR) Prices 4.26M Share Offering at $23.50/sh
-
-
-
-
-
-
-
Increasing unusual option volume: NKTR PAGS GXO SFIX HUYA NTS RZLV MAIN COTY
-
450,912 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

